FindTrial
Sign In

Effects of Oxycodone on Catheter-Related Bladder Discomfort after Ureteroscopic Lithotripsy

Effects of Oxycodone on Catheter-Related Bladder Discomfort after Ureteroscopic Lithotripsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120825
Enrollment
Unknown
Registered
2026-03-20
Start date
2026-01-30
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Interventions

Oxycodone group:Oxycodone is administered intravenously at a dose of 0.1 mg/ kg.
Control group:Administer an equal volume of normal saline intravenously.

Sponsors

Bao'an District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for ureteroscopic lithotripsy under general anesthesia; 2. Age 18-65 years.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of diabetes or Parkinson's disease, or those with a preoperatively indwelling urinary catheter; 2. Patients with contraindications to the investigational drug; 3. Patients accompanied by severe dysfunction of the heart, lungs, liver, kidneys, or other major organs.

Design outcomes

Primary

MeasureTime frame
incidence of catheter-related bladder discomfort (CRBD);grade of catheter-related bladder discomfort (CRBD);—

Secondary

MeasureTime frame
depth of sedation;nausea and vomiting;dizziness;Respiratory Depression;—

Countries

China

Contacts

Public ContactChen Li

Shenzhen Bao'an Traditional Chinese Medicine Hospital (The Seventh Clinical Medical College of Guangzhou University of Chinese Medicine), Shenzhen

chenli19750410@126.com+86 180 2548 6596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026